Candida blankii

Last updated

Candida blankii
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Eukaryota
Kingdom: Fungi
Division: Ascomycota
Class: Saccharomycetes
Order: Saccharomycetales
Family: Saccharomycetaceae
Genus: Candida
Species:
C. blankii
Binomial name
Candida blankii
H.R. Buckley & Uden, 1968
Synonyms [1] [2]

Candida hydrocarbofumaricaK. Yamada, T. Furuk. & Nakahara, 1974

Contents

Candida blankii is a species of budding yeast (Saccharomycotina) in the family Saccharomycetaceae. [3] [4] The yeast may be a dangerous pathogen and resistant to treatment in human hosts. Research on the fungi has therapeutic, medical and industrial implications.

Taxonomy

Candida blankii was discovered in the 1960s, after the analysis of the organs of infected mink in Canada by F. Blank. These mink were infected with the unknown yeast, and all died from mycosis. [5] [6] [7] It was described in 1968 by H. R. Buckley and N. van Uden, who named it in honour of Blank. [5] [8] The description was published in the journal Mycopathologia et Mycologia Applicata , along with descriptions of four other new species. [6]

Identification

On Sabouraud dextrose agar, C. blankii isolates present as typical yeast, i.e., cream-colored colonies, which then tend toward pink and later dark blue. Blood sample DNA sequencing of the 26S ribosomal subunit can definitively identify C. blankii. [3]

Ecology

In nature, Candida blankii forms symbiotic relationships with other organisms. An Indian study of seven bee species and 9 plant species found 45 yeast species from 16 genera colonise the nectaries of flowers and honey stomachs of bees. Most were members of the genus Candida ; the most common species in honey bee stomachs was Dekkera intermedia , while the most common species colonising flower nectaries was C. blankii. Although the mechanics are not fully understood, it was found that Azadirachta indica flowers more if C. blankii are present. [7]

Human pathology

A few human infections of Candida blankii have been found. Their existence suggests that the condition may have been under-reported. [3] In 2015, the yeast was found in the airways of a patient with cystic fibrosis; this was the first recorded case of C. blankii infection in humans. [5] A second case was reported in 2018. The fungus proved resistant to treatment with antifungals. The yeast was characterized as "an opportunist pathogen for lung transplant and/or CF patients". [3] Because of its resistance, it was said to warrant further study. [3] [9] Different strains, it was suggested, should also be studied "to increase knowledge of genetic diversity and antifungal susceptibility profile". [3]

Fungal blood-stream infections (fungaemia) have been newly associated with C blankii. [9] Polyene antifungals have been identified as a possible treatment. [3]

The species has been detected in meat intended for human consumption, including Iberian ham. [10]

Biotechnology

Like many yeasts, Candida blankii has been the subject of various biotechnological studies, [11] [12] including for use as a BOD biosensor. [13] [14] The metabolic process of C. blankii is aerobic. Consequently, it oxidizes many forms of alcohol, amino acid, carbohydrates, and other organic compounds. As a BOD biosensor, practical applications may be limited due to short term effectiveness. [note 1]

A diploid isolate of C. blankii had an observed "potential for use in single cell protein production from hemicellulose hydrolysates", which is related to Cellulosic ethanol (i.e., ethanol production). [15]

This yeast is one of several studied extensively for use in xylose fermentation. [16] [17]

Candida blankii has been tested as an aid for the degradation of hemicellulose hydrolysates. [18] C. blankii "cultivated on a mixture of n-paraffins (6% vol/vol) has been shown to produce fumaric acid", which could be important in ethanol production, once the process is worked out. [19] [20]

See also

Notes

  1. ↑ It has been tested as a water quality indicator in comparison to a pair of other Candida species. Its growth phase (hours 14 through 38) and lag phase (hours 0 through 14) were exceptional. However, maximum oxidative activity is typically about 18 hours throughout its lifespan, and biosensor activity declines by half in a little over a week. [14]

Related Research Articles

<span class="mw-page-title-main">Candidiasis</span> Fungal infection due to any type of Candida

Candidiasis is a fungal infection due to any species of the genus Candida. When it affects the mouth, in some countries it is commonly called thrush. Signs and symptoms include white patches on the tongue or other areas of the mouth and throat. Other symptoms may include soreness and problems swallowing. When it affects the vagina, it may be referred to as a yeast infection or thrush. Signs and symptoms include genital itching, burning, and sometimes a white "cottage cheese-like" discharge from the vagina. Yeast infections of the penis are less common and typically present with an itchy rash. Very rarely, yeast infections may become invasive, spreading to other parts of the body. This may result in fevers along with other symptoms depending on the parts involved.

<span class="mw-page-title-main">Yeast</span> Informal group of fungi

Yeasts are eukaryotic, single-celled microorganisms classified as members of the fungus kingdom. The first yeast originated hundreds of millions of years ago, and at least 1,500 species are currently recognized. They are estimated to constitute 1% of all described fungal species.

<i>Candida albicans</i> Species of fungus

Candida albicans is an opportunistic pathogenic yeast that is a common member of the human gut flora. It can also survive outside the human body. It is detected in the gastrointestinal tract and mouth in 40–60% of healthy adults. It is usually a commensal organism, but it can become pathogenic in immunocompromised individuals under a variety of conditions. It is one of the few species of the genus Candida that cause the human infection candidiasis, which results from an overgrowth of the fungus. Candidiasis is, for example, often observed in HIV-infected patients. C. albicans is the most common fungal species isolated from biofilms either formed on (permanent) implanted medical devices or on human tissue. C. albicans, C. tropicalis, C. parapsilosis, and C. glabrata are together responsible for 50–90% of all cases of candidiasis in humans. A mortality rate of 40% has been reported for patients with systemic candidiasis due to C. albicans. By one estimate, invasive candidiasis contracted in a hospital causes 2,800 to 11,200 deaths yearly in the US. Nevertheless, these numbers may not truly reflect the true extent of damage this organism causes, given new studies indicating that C. albicans can cross the blood–brain barrier in mice.

<span class="mw-page-title-main">Lactoferrin</span> Mammalian protein found in Homo sapiens

Lactoferrin (LF), also known as lactotransferrin (LTF), is a multifunctional protein of the transferrin family. Lactoferrin is a globular glycoprotein with a molecular mass of about 80 kDa that is widely represented in various secretory fluids, such as milk, saliva, tears, and nasal secretions. Lactoferrin is also present in secondary granules of PMNs and is secreted by some acinar cells. Lactoferrin can be purified from milk or produced recombinantly. Human colostrum has the highest concentration, followed by human milk, then cow milk (150 mg/L).

<i>Candida</i> (fungus) Genus of ascomycete fungi

Candida is a genus of yeasts. It is the most common cause of fungal infections worldwide and the largest genus of medically important yeast.

Cellulosic ethanol is ethanol produced from cellulose rather than from the plant's seeds or fruit. It can be produced from grasses, wood, algae, or other plants. It is generally discussed for use as a biofuel. The carbon dioxide that plants absorb as they grow offsets some of the carbon dioxide emitted when ethanol made from them is burned, so cellulosic ethanol fuel has the potential to have a lower carbon footprint than fossil fuels.

<i>Pseudomonas aeruginosa</i> Species of bacterium

Pseudomonas aeruginosa is a common encapsulated, Gram-negative, aerobic–facultatively anaerobic, rod-shaped bacterium that can cause disease in plants and animals, including humans. A species of considerable medical importance, P. aeruginosa is a multidrug resistant pathogen recognized for its ubiquity, its intrinsically advanced antibiotic resistance mechanisms, and its association with serious illnesses – hospital-acquired infections such as ventilator-associated pneumonia and various sepsis syndromes. P. aeruginosa is able to selectively inhibit various antibiotics from penetrating its outer membrane - and has high resistance to several antibiotics, according to the World Health Organization P. aeruginosa poses one of the greatest threats to humans in terms of antibiotic resistance.

<span class="mw-page-title-main">Fungemia</span> Internal, blood-borne infection by fungi, including yeasts.

Fungemia is the presence of fungi or yeasts in the blood. The most common type, also known as candidemia, candedemia, or systemic candidiasis, is caused by Candida species; candidemia is also among the most common bloodstream infections of any kind. Infections by other fungi, including Saccharomyces, Aspergillus and Cryptococcus, are also called fungemia. It is most commonly seen in immunosuppressed or immunocompromised patients with severe neutropenia, cancer patients, or in patients with intravenous catheters. It has been suggested that otherwise immunocompetent patients taking infliximab may also be at a higher risk for fungemia.

<i>Nakaseomyces glabratus</i> Species of fungus

Nakaseomyces glabratus is a species of haploid yeast of the genus Nakaseomyces, previously known as Candida glabrata. Despite the fact that no sexual life cycle has been documented for this species, N. glabratus strains of both mating types are commonly found. C. glabrata is generally a commensal of human mucosal tissues, but in today's era of wider human immunodeficiency from various causes, N. glabratus is often the second or third most common cause of candidiasis as an opportunistic pathogen. Infections caused by N. glabratus can affect the urogenital tract or even cause systemic infections by entrance of the fungal cells in the bloodstream (Candidemia), especially prevalent in immunocompromised patients.

Microbial genetics is a subject area within microbiology and genetic engineering. Microbial genetics studies microorganisms for different purposes. The microorganisms that are observed are bacteria, and archaea. Some fungi and protozoa are also subjects used to study in this field. The studies of microorganisms involve studies of genotype and expression system. Genotypes are the inherited compositions of an organism. Genetic Engineering is a field of work and study within microbial genetics. The usage of recombinant DNA technology is a process of this work. The process involves creating recombinant DNA molecules through manipulating a DNA sequence. That DNA created is then in contact with a host organism. Cloning is also an example of genetic engineering.

<span class="mw-page-title-main">Echinocandin</span> Group of chemical compounds

Echinocandins are a class of antifungal drugs that inhibit the synthesis of β-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-β glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria. β-glucans are carbohydrate polymers that are cross-linked with other fungal cell wall components, the fungal equivalent to bacterial peptidoglycan. Caspofungin, micafungin, and anidulafungin are semisynthetic echinocandin derivatives with limited clinical use due to their solubility, antifungal spectrum, and pharmacokinetic properties.

<span class="mw-page-title-main">Sterol 14-demethylase</span> Class of enzymes

In enzymology, a sterol 14-demethylase (EC 1.14.13.70) is an enzyme of the cytochrome P450 (CYP) superfamily. It is any member of the CYP51 family. It catalyzes a chemical reaction such as:

<span class="mw-page-title-main">Alcohol oxidase</span>

In enzymology, an alcohol oxidase (EC 1.1.3.13) is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Vaginal yeast infection</span> Medical condition

Vaginal yeast infection, also known as candidal vulvovaginitis and vaginal thrush, is excessive growth of yeast in the vagina that results in irritation. The most common symptom is vaginal itching, which may be severe. Other symptoms include burning with urination, a thick, white vaginal discharge that typically does not smell bad, pain during sex, and redness around the vagina. Symptoms often worsen just before a woman's period.


Moesziomyces antarcticus is a species of fungus in the order Ustilaginales. The species occurs as a yeast and was originally isolated from Antarctic lake sediment. It is a rare cause of human fungaemia infections.

<i>Candida auris</i> Species of fungus

Candida auris is a species of fungus that grows as yeast. It is one of the few species of the genus Candida which cause candidiasis in humans. Often, candidiasis is acquired in hospitals by patients with weakened immune systems. C. auris can cause invasive candidiasis (fungemia) in which the bloodstream, the central nervous system, and internal organs are infected. It has attracted widespread attention because of its multiple drug resistance. Treatment is also complicated because it is easily misidentified as other Candida species.

Invasive candidiasis is an infection (candidiasis) that can be caused by various species of Candida yeast. Unlike Candida infections of the mouth and throat or vagina, invasive candidiasis is a serious, progressive, and potentially fatal infection that can affect the blood (fungemia), heart, brain, eyes, bones, and other parts of the body.

<i>Candida tropicalis</i> Species of fungus

Candida tropicalis is a species of yeast in the genus Candida. It is a common pathogen in neutropenic hosts, in whom it may spread through the bloodstream to peripheral organs. For invasive disease, treatments include amphotericin B, echinocandins, or extended-spectrum triazole antifungals.

Candida hypersensitivity is a pseudoscientific syndrome promoted by William G. Crook, M.D. It is spuriously claimed that chronic yeast infections are responsible for many common disorders and non-specific symptoms including fatigue, weight gain, constipation, dizziness, muscle and joint pain, asthma, and others.

Candida haemulonii is a yeast fungal pathogen that is known to cause infections in humans. C. haemulonii is an emerging opportunistic pathogen that is found in hospitals and healthcare settings. Infections are difficult to treat because the fungus has resistance to antifungal agents. Since its emergence, little research has been conducted on this fungus. However, in recent years, research has been conducted to help identify the various properties of C. haemulonii.

References

  1. ↑ "Synonymy: Candida blankii". Species Fungorum . Retrieved 24 March 2019.
  2. ↑ "Candida blankii". MycoBank . Retrieved 24 March 2019.
  3. 1 2 3 4 5 6 7 João Nobrega de Almeida, Jr; Silvia V. Campos; Danilo Y. Thomaz; Luciana Thomaz; Renato K. G. de Almeida; Gilda M. B. Del Negro; Viviane F. Gimenes; Rafaella C. Grenfell; Adriana L. Motta; Flávia Rossi; Gil Benard (2018). "Candida blankii: an emergent opportunistic yeast with reduced susceptibility to antifungals". Emerging Microbes & Infections . 7 (1): 24. doi: 10.1038/s41426-017-0015-8 . PMC   5841406 . PMID   29515103.
  4. ↑
  5. 1 2 3 Zaragoza S, Galanternik L, Vazquez M, Teper A, Córdoba S, Finquelievich J (2015). "Candida blankii: New agent in cystic fibrosis airways?". Journal of Cystic Fibrosis. 14: S140. doi: 10.1016/S1569-1993(15)30492-6 .
  6. 1 2 Buckley, H. R.; van Uden, N. (1968). "Five new Candida species". Mycopathologia et Mycologia Applicata . Kluwer Academic Publishers. 36 (3–4): 257–266. doi:10.1007/BF02050372. ISSN   0027-5530. PMID   5750670. S2CID   42208175. Online.
  7. 1 2 Sandhu DK, Waraich MK (1985). "Yeasts associated with pollinating bees and flower nectar". Microbial Ecology. 11 (1): 51–58. doi:10.1007/BF02015108. JSTOR   4250820. PMID   24221239. S2CID   1776642.
  8. ↑ Page image list, Index of Fungi 3: 506 (1961–1970) Libri fungorum
  9. 1 2 Al-Haqqan A, Al-Sweih N, Ahmad S, Khan S, Joseph L, Varghese S, Khan Z (2018). "New resistant microbes in humans: Azole-resistant Candida blankii as a newly recognized cause of bloodstream infection". New Microbes and New Infections . 26: 25–29. doi:10.1016/j.nmni.2018.06.008. PMC   6141729 . PMID   30245830.
  10. ↑ Toldrá, Fidel (October 2014). Toldrá, Fidel; Hui, Y. H.; Astiasaran, Iciar; Sebranek, Joseph; Talon, Regine (eds.). Handbook of Fermented Meat and Poultry (2nd ed.). Chichester, West Sussex, UK: Wiley-Blackwell. p. 140. ISBN   978-1-118-52267-7.
  11. ↑ Hristozovaa T, Gotchevab V, Tzvetkovaa B, Paskalevaa D, Angelov A (September 2008). "Enzyme and Microbial Technology: Effect of furfural on nitrogen assimilating enzymes of lactose utilizing yeasts Candida blankii 35 and Candida pseudotropicalis". Enzyme and Microbial Technology . 43 (3, 5): 284–288. doi:10.1016/j.enzmictec.2008.03.014.
  12. ↑ Ying Zhao; Jasper Fuk-Woo Chan; Chi-Ching Tsang; He Wang; Dawen Guo; Yuhong Pan; Yuling Xiao; Na Yue; Jonathan Hon-Kwan Chen; Susanna Kar-Pui Lau; Yingchun Xu; Patrick Chiu-Yat Woo (2015). D. W. Warnock (ed.). "Clinical Characteristics, Laboratory Identification, and In Vitro Antifungal Susceptibility of Yarrowia (Candida) lipolytica Isolates Causing Fungemia: a Multicenter, Prospective Surveillance Study". Journal of Clinical Microbiology. American Society for Microbiology. 53 (11): 3639–3645. doi:10.1128/JCM.01985-15. PMC   4609733 . PMID   26311865.
  13. ↑ Meyer, P. S.; Du Preez, J. C.; Kilian, S. G. (1992). "Chemostat cultivation of Candida blankii on sugar cane bagasse hemicellulose hydrolysate". Biotechnology and Bioengineering . 40 (3): 353–358. doi:10.1002/bit.260400304. PMID   18601125. S2CID   32148823.
  14. 1 2 Arlyapova, Viacheslav; Kamanina, Stanislav; Ponamorevaa, Olga; Reshetilov, Anatoly (2012). "Biosensor analyzer for BOD index express control on the basis of the yeast microorganisms Candida maltosa, Candida blankii, and Debaryomyces hansenii". Enzyme and Microbial Technology . 50 (4–5): 215–20. doi:10.1016/j.enzmictec.2012.01.002. PMID   22418260.
  15. ↑ Meyer PS, du Preez JC, Wingfield BD, Kilian SG (June 1993). "Evaluation of Candida blankii hybrids for biomass production". Journal of Biotechnology . 29 (3): 267–275. doi:10.1016/0168-1656(93)90058-U.
  16. ↑ Singh, Om V.; Harvey, Steven P., eds. (November 25, 2009). Sustainable Biotechnology: Sources of Renewable Energy. Dordrecht London: Springer. pp. 71, 77. ISBN   9789048132959.
  17. ↑ Walker, Graeme M. (April 1, 1998). Yeast Physiology and Biotechnology (1st ed.). Chichester New York: John Wiley & Son. p. 230. ISBN   0471964476.
  18. ↑ Meyer PS, Du Preez JC, Kilian SG (1992). "Effect of temperature and pH on Candida blankii in chemostat culture". World Journal of Microbiology & Biotechnology . 8 (4): 434–438. doi:10.1007/BF01198761. ISSN   0959-3993. PMID   24425519. S2CID   689861.
  19. ↑ Hui, Y. H. (1995). Khachatourians, George G. (ed.). Food Biotechnology: Microorganisms. John Wiley & Sons. p. 341. ISBN   0471185701.
  20. ↑ Tsekova K, Kaimaktchiev A, Krumov A (1999). "Production of Fumaric Acid from n-Alcanes by Candida Blankii NA-83". Biotechnology & Biotechnological Equipment . 13 (2): 24–26. doi: 10.1080/13102818.1999.10819032 .
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.